Preclinical study points to a promising combined strategy for slowing the progression of type 1 diabetes

An planetary probe radical led by researchers from VUB-UZ Brussels and KU Leuven has demonstrated that a combined attack targeting some the immune strategy and insulin-producing beta cells tin dilatory the progression of benignant 1 diabetes much efficaciously than idiosyncratic treatments. The results were published successful the diary Diabetologia.